Oral beclomethasone dipropionate in pediatric active ulcerative colitis: A comparison trial with mesalazine

Journal of Pediatric Gastroenterology and Nutrition

Volumn 50, Issue 4, 2010, Pages 385-389

  Romano, Claudio ^a   Famiani, Annalisa ^a   Comito, Donatella ^a   Rossi, Paolo ^a   Raffa, Vanessa ^a   Fries, Walter ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Beclomethasone; Glucocorticoids; Mesalazine; Therapy; Ulcerative colitis

Indexed keywords

BECLOMETASONE DIPROPIONATE; C REACTIVE PROTEIN; HYDROCORTISONE; MESALAZINE;

ABDOMINAL PAIN; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAINTENANCE THERAPY; MALE; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; REMISSION; SCHOOL CHILD; STATISTICAL ANALYSIS; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; FEMALE; HUMANS; MALE; MESALAMINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77950225668     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181bb3457     Document Type: Article

References (38)

1. Kim SC, Ferry GD. Inflammatory bowel diseases in paediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology 2004;126:1550-1560
2. Nieuwenhuis EE, Escher JC. Early onset IBD: what's the difference? Dig Liver Dis 2008;40:12-15
3. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastreonterol 2004;99:1371-1385
4. Hanauer SB. New lessons: classic treatments, expanding options in ulcerative colitis. Colorectal Dis 2006;8 (Suppl I):20-24
5. Marshall JK, Irvine EJ. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Am J Gastroenterol 2000;95:1628-1636
6. Gionchetti P, Rizzello F, Morselli C, et al. Review article: aminosalicylates for distal colitis. Aliment Pharmacol Ther 2006;24 (Suppl 3): 41-44
7. Hanauer SB. Medical therapy for ulcerative colitis 2004. Gastroenterology 2004;126:1582-1592
8. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on therapeutic trial. Br Med J 1955;2:1041-1048
9. Truelove SC. Systemic and local corticosteroid therapy in ulcerative colitis. Br Med J 1960;5171:464-467
10. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a populationbased study. Gastroenterology 2001;121:255-260
11. Hanauer SB, Stathopoulos G. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease. Drug Saf 1991;6:192-219.
12. Heuschkel R, Salvestrini C, Beattie RM, et al. Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 2008;14:839-849
13. Cowan FJ, Warner JT, Dunstan FD, et al. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997;76: 325-329
14. Orchard T, Probert CS, Keshav S. Review article: maintenance therapy in patients with ulcerative colitis. Aliment Pharmacol Ther 2006;24 (Suppl 1):17-22.
15. Campieri M. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. Gut 2002;50 (Suppl 3):43-46
16. Rizzello F, Gionchetti P, Galeazzi R, et al. Oral beclomethasone dipropionate in patients with mild-to-moderate ulcerative colitis: a dose-finding study. Adv Ther 2001;18:261-271
17. Adams NP, Bestall JB, Malouf R, et al. Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev 2005; CD002738.
18. Manguso F, Balzano A. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild-to-moderate distal ulcerative colitis. Aliment Pharmacol Ther 2007;26:21-29
19. Rizzello F, Gionchetti P, D'Arienzo A, et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2002;16:1109-1116
20. Campieri M, Adamo S, Valpiani D, et al. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. Aliment Pharmacol Ther 2003;17:1471-1480
21. Felici E, Trail L, Raselli B, et al. Oral beclomethasone diproprionate: a pilot studyin children with ulcerative colitis. Dig Liver Dis 2006; 38:A27.
22. Tomomasa T, Kobayashi A, Ushijima K, et al. Guidelines for treatment of ulcerative colitis in children. Pediatr Int 2004;46:494-496
23. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a paediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007;133:423-432
24. Baron JH. Inflammatory bowel disease up to 1932. Mt Sinai J Med 2000;67:174-189
25. Maier K, von Gaisberg U, Kraus B. Ulcerative colitis. Activity index for the clinical and histological classification of inflammatory activity. Schweiz Med Wochenschr 1988;118:763-766
26. Daley-Yates PT, Price AC, Sisson JR, et al. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001;51:400-409
27. Biancone L, Gionchetti P, Blanco Gdel V, et al. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Dig Liver Dis 2007;39:329-337
28. Löfberg R, Danielsson A, Suhr O, et al. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology 1996;110:1713-1718
29. Hanauer SB, Robinson M, Pruitt R, et al. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a doseranging study. U.S. Budesonide enema study group. Gastroenterology 1998;115:525-532
30. Lémann M, Galian A, Rutgeerts P, et al. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1995;9:557-562
31. Barden L, Lipson A, Pert P, et al. Mesalazine in childhood inflammatory bowel disease. Aliment Pharmacol Ther 1989;3:597-603.
32. Kirschner BS. Differences in the management of inflammatory bowel disease in children and adolescents compared to adults. Neth J Med 1998;53:S13-8.
33. van Bodegraven AA, Mulder CJ. Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? World J Gastroenterol 2006;14:6115-6123
34. Turunen P, Ashorn M, Auvinen A, et al. Long-term health outcomes in paediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2009;15:56-62.
35. Hyams JS, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children. J Pediatr 1996;129:81-88
36. Howarth LJ, Wiskin AE, Griffiths DM, et al. Outcome of childhood ulcerative colitis at 2 years. Acta Paediatr 2007;96:1790-1793
37. Cohen RD, Waseth DM, Thisted RA, et al. A meta-analysis and overview of the literature for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000;95:1263-1276
38. Marshall JK, Ilrvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 1995;9:293-300.